We are very pleased to support the 6th Cambridge International Stem Cell Symposium from 19 - 21 September. The annual event held by the University of Cambridge will bring together more than 400 delegates, from students to professors, to discuss the biggest fundamental and translational questions as well as celebrate the great advances being made in stem cell biology all around the world.
Our team of experts is going to be there and they would be delighted to meet with you and discuss how our range of human cells and custom stem cell and iPSC services can aid your study and research.
Also, make sure you stop by our Poster presentations where our scientists are going to present new data about Human iPSC-derived Microglia and Human iPSC-derived Atrial Cardiomyocytes; the latest additions on Axol's product portfolio.
Improving Models of Microglia: The Development of Physiologically Functional Human iPSC-derived Microglia
Presenter: Dan Rock, Scientist at Axol Bioscience
Date & Time: September 19 17:30 - 19:00
Location: NO 70
In Vitro Validation of Human iPSC-derived Atrial Cardiomyocytes for Cell-based Assays and Drug Discovery
Presenter: Steven Broadbent, Scientist at Axol Bioscience
Date & Time: September 19 17:30 - 19:00
Location: NO 20
Source: https://www.axolbio.com/
Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery